Lista de obras -

2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.

artículo científico publicado en 2018

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.

artículo científico publicado en 2017

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

scientific article published on 07 April 2020

A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

artículo científico publicado en 2012

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

artículo científico publicado en 2008

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

artículo científico publicado en 2009

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.

artículo científico publicado en 2010

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

artículo científico publicado en 2008

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system

artículo científico publicado en 2014

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

artículo científico publicado en 2012

Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress

artículo científico publicado en 2012

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.

artículo científico publicado en 2013

Cannabinoid system and neuroinflammation: implications for multiple sclerosis.

artículo científico publicado en 2007

Chemical probes for the recognition of cannabinoid receptors in native systems

artículo científico publicado en 2012

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

artículo científico publicado en 2005

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

artículo científico publicado en 2007

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

scientific article published on 14 March 2017

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis

scientific article published on 30 August 2018

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

artículo científico publicado en 2018

Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: Relevance for in vitro studies with cannabinoids in motor neuron diseases ⬇️

artículo científico publicado el 22 de diciembre de 2011

Microglia activation states and cannabinoid system: Therapeutic implications.

artículo científico publicado en 2016

Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites

artículo científico publicado en 2013

PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

artículo científico publicado en 2015

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

artículo científico publicado en 2005

Regulatory lymphocytes are key factors in MHC-independent resistance to EAE

artículo científico publicado en 2014

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

artículo científico publicado en 2008

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

artículo científico publicado en 2011

The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis.

scientific article published on January 2009

Therapeutic potential of CB2 targeting in multiple sclerosis

artículo científico publicado en 2008

Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.

artículo científico publicado en 2012

[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis]

scientific article published on 01 November 2006

[Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]

artículo científico publicado en 2012

Lista de obras de

2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.

2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.

A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress

Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.

Cannabinoid system and neuroinflammation: implications for multiple sclerosis.

Chemical probes for the recognition of cannabinoid receptors in native systems

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: Relevance for in vitro studies with cannabinoids in motor neuron diseases ⬇️

Microglia activation states and cannabinoid system: Therapeutic implications.

Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites

PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

Regulatory lymphocytes are key factors in MHC-independent resistance to EAE

Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide

The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.

The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis.

Therapeutic potential of CB2 targeting in multiple sclerosis

Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.

[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis]

[Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]